APA (7th ed.) Citation

JA, F., MP, L., HA, P., WL, v. P., H, P., JG, K., . . . Klijn, J. G. (1995). Urokinase-type plasminogen activator and its inhibitor PAI-1: Predictors of poor response to tamoxifen therapy in recurrent breast cancer. JNCI: Journal of the National Cancer Institute, 87(10), 751. https://doi.org/10.1093/jnci/87.10.751

Chicago Style (17th ed.) Citation

JA, Foekens, et al. "Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1: Predictors of Poor Response to Tamoxifen Therapy in Recurrent Breast Cancer." JNCI: Journal of the National Cancer Institute 87, no. 10 (1995): 751. https://doi.org/10.1093/jnci/87.10.751.

MLA (9th ed.) Citation

JA, Foekens, et al. "Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1: Predictors of Poor Response to Tamoxifen Therapy in Recurrent Breast Cancer." JNCI: Journal of the National Cancer Institute, vol. 87, no. 10, 1995, p. 751, https://doi.org/10.1093/jnci/87.10.751.